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Intermittent claudication is characterized by cramping pain, discomfort, or fatigue in
the lower limbs that is elicited by exercise and relieved by rest. Typically, the amount
of exercise that initiates the symptoms is more or less constant, forcing a patient to
pause at regular distances while walking. Over time, patients may develop more
severe symptoms, such as ischemic rest pain, ulcers, or gangrene. In a small minority
of the patients amputation of the lower limb is eventually required. The symptoms of
intermittent claudication are explained by impaired blood flow to the lower limbs
caused by atherosclerotic obstructions in the peripheral arterial system.
Treatment alternatives include exercise, bypass surgery, and, more recently,
percutaneous transluminal angioplasty. Traditionally, the approach to treating
intermittent claudication has been conservative, because patients face little risk of limb
loss and because the risks of perioperative complications from surgical
revascularization procedures are significant (Chapter 1). Interventions are generally
postponed until initial non-interventional options such as exercise have failed. The
risks of perioperative complications from angioplasty, are, however, far lower than
those of bypass surgery and the question has been raised whether the conservative
approach to treating intermittent claudication can still be justified as earlier
intervention may prevent unnecessary disability. On the other hand, the costs of both
types of vascular interventions are considerable. Considering the limitations of the
health care resources, it is even possible that current treatment strategies are not
conservative enough and that, from a cost-effectiveness perspective, vascular
interventions would better be reserved for patients with more severe symptoms of
peripheral arterial occlusive disease.
The primary purpose of the work presented in this thesis was to evaluate the cost-
effectiveness of interventional and non-interventional treatment strategies in patients
with intermittent claudication. We developed a Markov decision model that simulates
outcomes, both costs and effects, under several alternative treatment strategies. Results
of the decision analysis are presented in Chapter 9. Most of the other studies presented
in this thesis were preliminary steps that provided input information for the decision
model.
In Chapter 2 we examined the value of certain patient characteristics and vascular
laboratory measures in predicting the outcomes of an exercise program for patients
with intermittent claudication. This analysis was presented as an example of the use of
autoregressive logistic regression, a statistical technique that may be particularly
useful if primary data is analyzed to provide input data for a Markov decision
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analysis. We found that age, duration of the symptoms, and the ankle/brachial index
may help to predict the outcomes of the exercise program.
The effect measure that was used in the decision analysis adjusts a patient's l i fe
expectancy for the effects of disease and disabil ity on the quality of l i fe. Quality
weights may be obtained with health value measures, questionnaires that aim to
measure quality of l i fe on a 0-1 scale. ln Clnpter 3 we used several such measures,
including the time trade-off, standard gamble, verbal rating scale, Health Util i t ies
Index, and the EuroQol, and explored their relation with a measure of symptom
severity, the symptom-free walking distance, of the respondents. The strongest
statistical association between health values and walkinq distance was found for the
EuroQol and the verbal rating scale.
In Chnpter 4 we discussed the use of summary ROC curves in combinirrg data frorn
different published studies of the performance of a diagnostic test. In our study we
appiied the technique to studies of the diagnostic performance of dupiex scanning in
peripheral arterial occlusive disease. Usually, such studies report estimates of the
sensitivity and specificity of the test. A summary ROC curve adjusts for differences
between the studies in the threshold value used that may have caused systematic
differences in sensitivity and specificity. The results of the analysis suggest that the
addition of color-flow imaging to duplex scanning improves its dia6;nostrc
performance and probably reduces the total imaging time.
In Chnpter 5 we determined the costs of a variety of vascuiar interrrentions. Data
were obtained from the hospital accounting database of Brigham and Women's
Hospital (Boston, United States). The resuits of a regression analysis suggest that
perioperative complications may have a significant effect on the total costs of a
hospital admission for bypass surgery or angioplasty. Additional effects were found
for age, sex, presenting symptoms, and history of coronary artery disease.
Chapter 6 is a meta-analysis of studies of the short- and long-term results of aortic
bifurcation bypass surgery in patients with peripheral arterial occlusive disease. An
important, but relatively rare long-term complication from this and other similar
procedures is occlusion of the bypass. Most studies in vascular surgery therefore use
'graft patency' as their primary outcome measure. Our analysis suggests that the risks
of perioperative mortality and morbidity (e.g., myocardial infarction) from this
procedure have declined during the past few decades, whereas the graft failure rates
remained constant.
A comparison of interventional and non-interventional treatment strategies in
peripheral arterial occlusive disease based on l iterature data is complicated by a
fundamental difference in reporting traditions between the different areas in vascular
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patency, whereas outcome studies of non-interventional therapy primarily report
functional outcomes, such as walking performance. Chapter 7 aimed to provide a link
between changes in ankle/brachial index, as used in patency criteria, and changes in
maximum walking distance.
Theoretically, ignoring the possibility that patients develop symptoms in the
contralateral limb may bias against therapeutic options that treat both limbs
simultaneously (e.g., exercise). In Chapter 8 we determined the incidence of
contralateral symptoms in patients with a unilateral intervention for peripheral arterial
occlusive disease. We found that the incidence of contralateral critical ischemia (i.e.,
rest pain, ulcer, or gangrene) is considerable, especially if the initial ipsilateral
procedure was also performed for critical ischemia or if the initial contralateral
ankle/brachial index was low.
Chapter 9 presented the results of a Markov decision analysis comparing
interventional and non-interventional treatment strategies for intermittent
claudication. A Markov decision model defines a number of different health states and
simulates how patients may move between the different health states under a
particular treatment strategy. The model keeps track of the time spent in each health
state and the accumulated costs. Treatment strategies included exercise, exercise and
angioplasty, or exercise, angioplasty and bypass surgery as possible therapeutic
options for intermittent claudication. We found that, compared to a treatment strategy
based exclusively on exercise, interventional treatment strategies improved the
quality-adjusted life expectancy, provided that patients did not have a history of
myocardial infarction or angina pectoris. The extra costs of interventional strategies,
however, were considerable. Relative to the gain in quality-adjusted life expectancy,
the extra costs of strategies that included bypass surgery (> 200,000 US-dollar per
quality-adjusted life year gained) were in fact much higher than what by most
standards would be regarded as acceptable. The exact timing of the intervention did
not seem to be a key issue: very similar results were obtained for strategies based on
primary intervention vs. those that considered intervention only if exercise failed.
These results suggest that current treatment strategies, which in many centers include
bypass surgery as a secondary treatment option may not be conservative enough, at
least from a cost-effectiveness perspective. Estimates of the extra costs relative to the
gains of strategies that included angioplasty as the only interventional therapeutic
option were comparable to those of other expensive, but currently accepted
technologies, though highly uncertain. We conclude that a future clinical trial among
patients with intermittent claudication would probably best be directed at comparing
an interventional treatment strategy based on angioplasty to a strictly non-
interventional treatment strategy.
